HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryoko Anada Selected Research

Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)

10/2021A Parkinson's disease patient displaying increased neuromelanin-sensitive areas in the substantia nigra after rehabilitation with tDCS: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryoko Anada Research Topics

Disease

1Movement Disorders (Movement Disorder)
10/2021
1Parkinson Disease (Parkinson's Disease)
10/2021
1Neuroinflammatory Diseases
06/2021
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2021
1Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
01/2021
1Polyneuropathies (Polyneuropathy)
01/2021
1Infections
10/2019
1Bacterial Meningitis
10/2019

Drug/Important Bio-Agent (IBA)

1Carboxy-LyasesIBA
10/2021
1Dopa DecarboxylaseIBA
10/2021
1Monoamine Oxidase (MAO)IBA
10/2021
13-Iodobenzylguanidine (Iobenguane)IBA
10/2021
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
10/2021
1neuromelaninIBA
10/2021
1Adenosine (Adenocard)FDA LinkGeneric
06/2021
1Adenosine Triphosphate (ATP)IBA
06/2021
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
10/2019
1Methicillin (Metin)FDA Link
10/2019

Therapy/Procedure

1Transcranial Direct Current Stimulation
10/2021
1Transcranial Magnetic Stimulation
10/2021
1Therapeutics
10/2019